Related references
Note: Only part of the references are listed.The Epidemiology of Herpes Zoster in Patients with Newly Diagnosed Cancer
Laurel A. Habel et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013
Joseph R. Mikhael et al.
MAYO CLINIC PROCEEDINGS (2013)
Herpes Zoster
Jeffrey I. Cohen
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Prognostic Risk Factor Evaluation in Patients With Relapsed or Refractory Multiple Myeloma Receiving Lenalidomide Treatment: Analysis of Renal Function by eGFR and of Additional Comorbidities by Comorbidity Appraisal
Martina Kleber et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2012)
Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity score
M. Kleber et al.
BLOOD CANCER JOURNAL (2011)
Decrease in CD4+ T-Cell Counts in Patients With Multiple Myeloma Treated With Bortezomib
Ulrike Heider et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2010)
Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)
Stefan Knop et al.
BLOOD (2009)
Does Bortezomib Induce De Facto Varicella Zoster Virus Reactivation in Patients With Multiple Myeloma?
Constantin A. Dasanu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study
Asher Chanan-Khan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Meletios Dimopoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America
Donna M. Weber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation
M Offidani et al.
CLINICAL INFECTIOUS DISEASES (2001)